95 related articles for article (PubMed ID: 8954825)
1. Bradykinin metabolism in the liver and lung of the rat.
Griswold JA; Beall CV; Baker CR; Little DT; Little GH; Behal FJ
J Surg Res; 1996 Nov; 66(1):12-20. PubMed ID: 8954825
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin metabolism in rat hind limbs.
Griswold JA; Baker CR; Little DT; Little GH; Behal FJ
Shock; 1998 Aug; 10(2):146-52. PubMed ID: 9721983
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin metabolism in perfused rat kidney.
Griswold JA; Baker CR; Little DT; Little GH; Behal FJ
Shock; 1999 May; 11(5):372-9. PubMed ID: 10353545
[TBL] [Abstract][Full Text] [Related]
4. Kinin metabolism in the perfused ventilated rat lung. I: Bradykinin metabolism in a system modeling the normal, uninjured lung.
Baker CR; Little AD; Little GH; Canizaro PC; Behal FJ
Circ Shock; 1991 Jan; 33(1):37-47. PubMed ID: 2009602
[TBL] [Abstract][Full Text] [Related]
5. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung.
Prechel MM; Orawski AT; Maggiora LL; Simmons WH
J Pharmacol Exp Ther; 1995 Dec; 275(3):1136-42. PubMed ID: 8531074
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation.
Erşahin C; Simmons WH
J Cardiovasc Pharmacol; 1997 Jul; 30(1):96-101. PubMed ID: 9268227
[TBL] [Abstract][Full Text] [Related]
7. Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin.
Oliveira EB; Martins AR; Camargo AC
Biochemistry; 1976 May; 15(9):1967-74. PubMed ID: 5120
[TBL] [Abstract][Full Text] [Related]
8. Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin.
Ryan JW; Berryer P; Chung AY; Sheffy DH
J Pharmacol Exp Ther; 1994 Jun; 269(3):941-7. PubMed ID: 8014881
[TBL] [Abstract][Full Text] [Related]
9. Endopeptidases (kininases) are able to hydrolyze kinins in tubular fluid along the rat nephron.
Casarini DE; Boim MA; Stella RC; Schor N
Am J Physiol; 1999 Jul; 277(1):F66-74. PubMed ID: 10409299
[TBL] [Abstract][Full Text] [Related]
10. Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart.
Ahmad M; Zeitlin IJ; Parratt JR; Pitt AR
Arch Pharm Res; 2006 Mar; 29(3):241-8. PubMed ID: 16596998
[TBL] [Abstract][Full Text] [Related]
11. Catabolism of vasoactive polypeptides by perfused rat liver.
Borges DR; Limãos EA; Prado JL; Camargo AC
Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):33-40. PubMed ID: 1004640
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
13. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart.
Dendorfer A; Wolfrum S; Wellhöner P; Korsman K; Dominiak P
Br J Pharmacol; 1997 Nov; 122(6):1179-87. PubMed ID: 9401784
[TBL] [Abstract][Full Text] [Related]
14. Conversion of T-kinin to bradykinin by the rat kidney.
Vieira MA; Moreira MF; Maack T; Guimarães JA
Biochem Pharmacol; 1994 Apr; 47(9):1693-9. PubMed ID: 8185685
[TBL] [Abstract][Full Text] [Related]
15. The effect of smoke inhalation on bradykinin metabolism by the perfused and ventilated rat lung.
Beall CV; Baker CR; Griswold JA; Little AD; Little GH; Behal FJ
J Burn Care Rehabil; 1995; 16(5):487-95. PubMed ID: 8537419
[TBL] [Abstract][Full Text] [Related]
16. Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme.
Sheikh IA; Kaplan AP
Biochem Pharmacol; 1986 Jun; 35(12):1951-6. PubMed ID: 3013204
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats.
Stanziola L; Greene LJ; Santos RA
Am J Hypertens; 1999 Oct; 12(10 Pt 1):1021-9. PubMed ID: 10560789
[TBL] [Abstract][Full Text] [Related]
18. A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma.
Shima C; Majima M; Katori M
Jpn J Pharmacol; 1992 Oct; 60(2):111-9. PubMed ID: 1479739
[TBL] [Abstract][Full Text] [Related]
19. Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates.
Oliveira EB; Souza LL; Sivieri DO; Bispo-da-Silva LB; Pereira HJ; Costa-Neto CM; Sousa MV; Salgado MC
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3550-7. PubMed ID: 17906107
[TBL] [Abstract][Full Text] [Related]
20. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
